Medical 21 Overview
- Founded
-
2016
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Angel
- (Announced)
- Latest Deal Amount
-
$40M
Medical 21 General Information
Description
Developer of an artificial graft designed to use in coronary bypass heart surgeries. The company's products include an artificial blood vessel as an alternative to harvesting blood vessels for coronary artery bypass surgeries, enabling cardio surgeons to make cardiac bypass surgery easier for patients and less expensive for the healthcare system.
Contact Information
Website
www.medical21.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
- 15070 23rd Avenue North
- Minneapolis, MN 55447
- United States
+1 (612) 000-0000
Medical 21 Timeline
Medical 21 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Angel (individual) | 28-Apr-2022 | $40M | 0000 | 00000 | Announced | Pre-Clinical Trials |
| 5. Later Stage VC | 15-Sep-2022 | 00.00 | 0000 | Completed | Pre-Clinical Trials | |
| 4. Seed Round | 30-Apr-2021 | 00.00 | 00.00 | Completed | Pre-Clinical Trials | |
| 3. Seed Round | 15-May-2019 | 00.000 | 000 | Completed | Pre-Clinical Trials | |
| 2. Angel (individual) | 01-Sep-2017 | $250K | $2.25M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 31-Mar-2017 | $2M | $2M | Completed | Pre-Clinical Trials |
Medical 21 Patents
Medical 21 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10954540-B2 | Methods of producing biosynthetic bacterial cellulose membranes | Active | 11-Dec-2015 | 000000000 | |
| EP-3386554-A4 | Methods of producing biosynthetic bacterial cellulose membranes | Pending | 11-Dec-2015 | 000000000 | |
| EP-3386554-A1 | Methods of producing biosynthetic bacterial cellulose membranes | Pending | 11-Dec-2015 | 000000000 | |
| AU-2016366783-B2 | Methods of producing biosynthetic bacterial cellulose membranes | Active | 11-Dec-2015 | 000000000 | |
| AU-2016366783-A1 | Methods of producing biosynthetic bacterial cellulose membranes | Active | 11-Dec-2015 | C12P19/04 |
Medical 21 Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Manny Villafana Ph.D | Founder, Chief Executive Officer & Chairman |
Medical 21 Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Manny Villafana Ph.D | Medical 21 | Founder, Chief Executive Officer & Chairman | 000 0000 |
Medical 21 Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
